Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity score matching
Wei et al., Frontiers in Pharmacology, doi:10.3389/fphar.2023.1274294
https://c19early.org/wei2pl.html